Table 1. Influence of clinical parameter on RFS.
Oropharynx stage III-IV | HNSCC stage III IV (TCGA) | |||
---|---|---|---|---|
HR (CI) | p | HR (CI) | p | |
Gender | 0.83 (0.37 - 1.86) | 0.646 | 0.89 (0.5 - 1.58) | 0.716 |
Age | 1 (0.97 - 1.03) | 0.901 | 1 (0.63 - 1.59) | 0.998 |
Stage | 2.38 (0.92 - 6.12) | 0.073 | 1.58 (0.91 - 2.75) | 0.106 |
Margin | 1.59 (1.14 - 2.23) | 0.007 ** | 1.54 (1.18 - 2) | 0.001** |
Alcohol/tobacco | 0.8 (0.24 - 2.61) | 0.708 | 1.01 (0.64 - 1.61) | 0.963 |
HPV | 0.43 (0.13 - 1.41) | 0.165 | 0.36 (0.05 - 2.74) | 0.327 |
NT5E | 0.64 (0.35 - 1.18) | 0.151 | 0.6 (0.38 - 0.94) | 0.027* |
MiR-422a | 1.99 (1.07 - 3.7) | 0.030 * | 3.03 (0.42 - 21.93) | 0.271 |